 | | HLL | | Name: | 1-[2-(1,2,3-triazol-1-yl)ethyl]imidazole-2-carboxylic acid | | Formula: | C8 H9 N5 O2 | | SMILES: | OC(=O)c1nccn1CCn2ccnn2 | | InChi: | InChI=1S/C8H9N5O2/c14-8(15)7-9-1-3-12(7)5-6-13-4-2-10-11-13/h1-4H,5-6H2,(H,14,15) | | Definition date: | 2021-01-19 | | Last modified: | 2022-01-14 | | Release date: | 2022-01-19 | | Identifier: | 1-[2-(1,2,3-triazol-1-yl)ethyl]imidazole-2-carboxylic acid |
|
 | | D82 | | Name: | beta-Saxitoxinol | | Formula: | C10 H17 N7 O3 | | SMILES: | NC(=O)OCC1NC(=N)N2CCC(O)C32NC(=N)NC13 | | InChi: | InChI=1S/C10H17N7O3/c11-7-15-6-4(3-20-9(13)19)14-8(12)17-2-1-5(18)10(6,17)16-7/h4-6,18H,1-3H2,(H2,12,14)(H2,13,19)(H3,11,15,16)/t4-,5-,6-,10+/m0/s1 | | Synonyms: | [(2Z,3aS,4R,6Z,7S,10S,10aS)-10-hydroxy-2,6-diiminooctahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate | | Definition date: | 2021-11-29 | | Last modified: | 2022-01-14 | | Release date: | 2022-01-19 | | Identifier: | [(2Z,3aS,4R,6Z,7S,10S,10aS)-10-hydroxy-2,6-diiminooctahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate |
|
 | | HM0 | | Name: | 1-cyclobutylimidazole-2-carboxylic acid | | Formula: | C8 H10 N2 O2 | | SMILES: | OC(=O)c1nccn1C2CCC2 | | InChi: | InChI=1S/C8H10N2O2/c11-8(12)7-9-4-5-10(7)6-2-1-3-6/h4-6H,1-3H2,(H,11,12) | | Definition date: | 2021-01-19 | | Last modified: | 2022-01-14 | | Release date: | 2022-01-19 | | Identifier: | 1-cyclobutylimidazole-2-carboxylic acid |
|
 | | HML | | Name: | 1-[[4-(trifluoromethyl)phenyl]methyl]imidazole-2-carboxylic acid | | Formula: | C12 H9 F3 N2 O2 | | SMILES: | OC(=O)c1nccn1Cc2ccc(cc2)C(F)(F)F | | InChi: | InChI=1S/C12H9F3N2O2/c13-12(14,15)9-3-1-8(2-4-9)7-17-6-5-16-10(17)11(18)19/h1-6H,7H2,(H,18,19) | | Definition date: | 2021-01-19 | | Last modified: | 2022-01-14 | | Release date: | 2022-01-19 | | Identifier: | 1-[[4-(trifluoromethyl)phenyl]methyl]imidazole-2-carboxylic acid |
|
 | | HN9 | | Name: | 1-[(4-hydroxyphenyl)methyl]imidazole-2-carboxylic acid | | Formula: | C11 H10 N2 O3 | | SMILES: | Oc1ccc(Cn2ccnc2C(O)=O)cc1 | | InChi: | InChI=1S/C11H10N2O3/c14-9-3-1-8(2-4-9)7-13-6-5-12-10(13)11(15)16/h1-6,14H,7H2,(H,15,16) | | Definition date: | 2021-01-19 | | Last modified: | 2022-01-14 | | Release date: | 2022-01-19 | | Identifier: | 1-[(4-hydroxyphenyl)methyl]imidazole-2-carboxylic acid |
|
 | | I0V | | Name: | (6R)-6-{2-[ethyl({4-[2-(ethylamino)ethyl]phenyl}methyl)amino]-4-methoxyphenyl}-5,6,7,8-tetrahydronaphthalen-2-ol | | Formula: | C30 H38 N2 O2 | | SMILES: | CCNCCc1ccc(cc1)CN(CC)c1cc(OC)ccc1C1Cc2ccc(O)cc2CC1 | | InChi: | InChI=1S/C30H38N2O2/c1-4-31-17-16-22-6-8-23(9-7-22)21-32(5-2)30-20-28(34-3)14-15-29(30)26-11-10-25-19-27(33)13-12-24(25)18-26/h6-9,12-15,19-20,26,31,33H,4-5,10-11,16-18,21H2,1-3H3/t26-/m1/s1 | | Definition date: | 2022-01-05 | | Last modified: | 2022-01-14 | | Release date: | 2022-01-19 | | Identifier: | (6R)-6-{2-[ethyl({4-[2-(ethylamino)ethyl]phenyl}methyl)amino]-4-methoxyphenyl}-5,6,7,8-tetrahydronaphthalen-2-ol |
|
 | | V85 | | Name: | (2R)-N,3-diphenyl-2-sulfanyl-propanamide | | Formula: | C15 H15 N O S | | SMILES: | S[CH](Cc1ccccc1)C(=O)Nc2ccccc2 | | InChi: | InChI=1S/C15H15NOS/c17-15(16-13-9-5-2-6-10-13)14(18)11-12-7-3-1-4-8-12/h1-10,14,18H,11H2,(H,16,17)/t14-/m1/s1 | | Synonyms: | N,3-diphenyl-2-sulfanylpropanamide | | Definition date: | 2021-04-26 | | Last modified: | 2022-01-14 | | Release date: | 2022-01-19 | | Identifier: | (2~{R})-~{N},3-diphenyl-2-sulfanyl-propanamide |
|
 | | VCW | | Name: | [(2S,3S,4S,5R,6S)-6-[(2R)-2,3-bis(oxidanyl)propoxy]-3,4,5-tris(oxidanyl)oxan-2-yl]methanesulfonic acid | | Formula: | C9 H18 O10 S | | SMILES: | OC[CH](O)CO[CH]1O[CH](C[S](O)(=O)=O)[CH](O)[CH](O)[CH]1O | | InChi: | InChI=1S/C9H18O10S/c10-1-4(11)2-18-9-8(14)7(13)6(12)5(19-9)3-20(15,16)17/h4-14H,1-3H2,(H,15,16,17)/t4-,5-,6-,7+,8-,9+/m1/s1 | | Synonyms: | sulfoquinovosyl glycerol | | Definition date: | 2021-05-05 | | Last modified: | 2022-01-14 | | Release date: | 2022-01-19 | | Identifier: | [(2~{S},3~{S},4~{S},5~{R},6~{S})-6-[(2~{R})-2,3-bis(oxidanyl)propoxy]-3,4,5-tris(oxidanyl)oxan-2-yl]methanesulfonic acid |
|
 | | JBC | | Name: | 5-[(E)-(3-carboxy-4-oxidanyl-phenyl)diazenyl]-2-oxidanyl-benzoic acid | | Formula: | C14 H10 N2 O6 | | SMILES: | OC(=O)c1cc(ccc1O)N=Nc2ccc(O)c(c2)C(O)=O | | InChi: | InChI=1S/C14H10N2O6/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22/h1-6,17-18H,(H,19,20)(H,21,22)/b16-15+ | | Definition date: | 2021-05-12 | | Last modified: | 2022-01-14 | | Release date: | 2022-01-19 | | Identifier: | 5-[(~{E})-(3-carboxy-4-oxidanyl-phenyl)diazenyl]-2-oxidanyl-benzoic acid |
|
 | | JBF | | Name: | 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid | | Formula: | C15 H9 F N2 O3 | | SMILES: | OC(=O)c1cccc(c1)c2noc(n2)c3ccccc3F | | InChi: | InChI=1S/C15H9FN2O3/c16-12-7-2-1-6-11(12)14-17-13(18-21-14)9-4-3-5-10(8-9)15(19)20/h1-8H,(H,19,20) | | Definition date: | 2021-05-12 | | Last modified: | 2022-01-14 | | Release date: | 2022-01-19 | | Identifier: | 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid |
|
 | | JBL | | Name: | 4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid | | Formula: | C21 H15 N3 O4 | | SMILES: | OC(=O)c1ccc(cc1)n2nc(nc2c3ccccc3O)c4ccccc4O | | InChi: | InChI=1S/C21H15N3O4/c25-17-7-3-1-5-15(17)19-22-20(16-6-2-4-8-18(16)26)24(23-19)14-11-9-13(10-12-14)21(27)28/h1-12,25-26H,(H,27,28) | | Definition date: | 2021-05-12 | | Last modified: | 2022-01-14 | | Release date: | 2022-01-19 | | Identifier: | 4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid |
|
 | | JBO | | Name: | 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]pyridine-3-carboxylic acid | | Formula: | C14 H11 F3 N2 O2 | | SMILES: | Cc1c(Nc2ncccc2C(O)=O)cccc1C(F)(F)F | | InChi: | InChI=1S/C14H11F3N2O2/c1-8-10(14(15,16)17)5-2-6-11(8)19-12-9(13(20)21)4-3-7-18-12/h2-7H,1H3,(H,18,19)(H,20,21) | | Definition date: | 2021-05-12 | | Last modified: | 2022-01-14 | | Release date: | 2022-01-19 | | Identifier: | 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]pyridine-3-carboxylic acid |
|
 | | JBR | | Name: | 4-[(3-carboxy-2-oxidanyl-naphthalen-1-yl)methyl]-3-oxidanyl-naphthalene-2-carboxylic acid | | Formula: | C23 H16 O6 | | SMILES: | OC(=O)c1cc2ccccc2c(Cc3c(O)c(cc4ccccc34)C(O)=O)c1O | | InChi: | InChI=1S/C23H16O6/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29/h1-10,24-25H,11H2,(H,26,27)(H,28,29) | | Definition date: | 2021-05-12 | | Last modified: | 2022-01-14 | | Release date: | 2022-01-19 | | Identifier: | 4-[(3-carboxy-2-oxidanyl-naphthalen-1-yl)methyl]-3-oxidanyl-naphthalene-2-carboxylic acid |
|
 | | E9F | | Name: | 4-(6-{1-[(R)-S-methanesulfonimidoyl]cyclopropyl}-2-[(3R)-3-methylmorpholin-4-yl]pyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridine | | Formula: | C20 H24 N6 O2 S | | SMILES: | CS(=N)(=O)C1(CC1)c1nc(nc(c1)c1ccnc2[NH]ccc21)N1CCOCC1C | | InChi: | InChI=1S/C20H24N6O2S/c1-13-12-28-10-9-26(13)19-24-16(14-3-7-22-18-15(14)4-8-23-18)11-17(25-19)20(5-6-20)29(2,21)27/h3-4,7-8,11,13,21H,5-6,9-10,12H2,1-2H3,(H,22,23)/t13-,29-/m1/s1 | | Definition date: | 2021-12-06 | | Last modified: | 2022-01-14 | | Release date: | 2022-01-19 | | Identifier: | 4-(6-{1-[(R)-S-methanesulfonimidoyl]cyclopropyl}-2-[(3R)-3-methylmorpholin-4-yl]pyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridine |
|
 | | WDP | | Name: | Sequanamycin 9 | | Formula: | C61 H102 N4 O20 S | | SMILES: | CC3C(OC1C(C(/CC(C)O1)=N/OC)O)C(C(C(C(=O)OC(C(C(C(C(C(C)(OC(=O)NC(C)(CNS(c2ccccc2)(=O)=O)C)C3)=O)C)OC(=O)CC(C)C)C)C(C)COC4C(C(C(C(C)O4)O)OC)OC)C)OC5OC(CN(C(C5)C)C)C)C | | InChi: | InChI=1S/C61H102N4O20S/c1-32(2)25-45(66)81-51-39(9)50(34(4)30-77-58-54(75-18)53(74-17)47(67)42(12)80-58)83-56(70)41(11)52(82-46-26-35(5)65(16)29-37(7)78-46)38(8)49(84-57-48(68)44(64-76-19)27-36(6)79-57)33(3)28-61(15,55(69)40(51)10)85-59(71)63-60(13,14)31-62-86(72,73)43-23-21-20-22-24-43/h20-24,32-42,46-54,57-58,62,67-68H,25-31H2,1-19H3,(H,63,71)/b64-44+/t33-,34-,35+,36+,37-,38+,39-,40+,41+,42+,46-,47+,48+,49-,50+,51+,52-,53+,54+,57-,58+,61-/m0/s1 | | Definition date: | 2020-10-19 | | Last modified: | 2022-01-14 | | Release date: | 2022-01-19 | | Identifier: | (2R,3S,4R,5R,7S,9S,10S,11R,12S,13R)-2-[(2S)-1-{[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}propan-2-yl]-10-{[(2S,3R,4E,6R)-3-hydroxy-4-(methoxyimino)-6-methyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-7-[({2-methyl-1-[(phenylsulfonyl)amino]propan-2-yl}carbamoyl)oxy]-6,14-dioxo-12-{[(2S,5R,7R)-2,4,5-trimethyl-1,4-oxazepan-7-yl]oxy}-1-oxacyclotetradecan-4-yl 3-methylbutanoate (non-preferred name) |
|
 | | V4J | | Name: | 2-{[(4R)-4-hydroxyhexyl]oxy}ethyl 5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoate | | Formula: | C18 H32 N2 O5 S | | SMILES: | C(CCC(OCCOCCCC(CC)O)=O)CC1C2C(CS1)NC(N2)=O | | InChi: | InChI=1S/C18H32N2O5S/c1-2-13(21)6-5-9-24-10-11-25-16(22)8-4-3-7-15-17-14(12-26-15)19-18(23)20-17/h13-15,17,21H,2-12H2,1H3,(H2,19,20,23)/t13-,14+,15+,17+/m1/s1 | | Definition date: | 2020-06-25 | | Last modified: | 2022-01-14 | | Release date: | 2022-01-19 | | Identifier: | 2-{[(4R)-4-hydroxyhexyl]oxy}ethyl 5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoate |
|
 | | WOV | | Name: | 2-(2,5-dimethyl-1H-pyrrol-1-yl)-5-hydroxybenzoic acid | | Formula: | C13 H13 N O3 | | SMILES: | c1(C)ccc(n1c2ccc(cc2C(O)=O)O)C | | InChi: | InChI=1S/C13H13NO3/c1-8-3-4-9(2)14(8)12-6-5-10(15)7-11(12)13(16)17/h3-7,15H,1-2H3,(H,16,17) | | Definition date: | 2020-11-02 | | Last modified: | 2022-01-14 | | Release date: | 2022-01-19 | | Identifier: | 2-(2,5-dimethyl-1H-pyrrol-1-yl)-5-hydroxybenzoic acid |
|
 | | XA4 | | Name: | (20R)-10,15,20-trimethyl-2-[(4-methylpiperazin-1-yl)methyl]-18,19,20,21-tetrahydro-15H,17H-12,8-(metheno)pyrazolo[3',4':2,3][1,5,10,12]oxatriazacycloheptadecino[12,11-a]benzimidazol-7(6H)-one | | Formula: | C30 H38 N8 O2 | | SMILES: | c2c1c6nc(cc(C(=O)N=C5N(CC(C)CCCOc1n(C)n2)c3c(ccc(c3)CN4CCN(CC4)C)N5)c6)C | | InChi: | InChI=1S/C30H38N8O2/c1-20-6-5-13-40-29-24(17-31-36(29)4)26-16-23(14-21(2)32-26)28(39)34-30-33-25-8-7-22(15-27(25)38(30)18-20)19-37-11-9-35(3)10-12-37/h7-8,14-17,20H,5-6,9-13,18-19H2,1-4H3,(H,33,34,39)/t20-/m1/s1 | | Definition date: | 2020-12-07 | | Last modified: | 2022-01-14 | | Release date: | 2022-01-19 | | Identifier: | (5aE,20R)-10,15,20-trimethyl-2-[(4-methylpiperazin-1-yl)methyl]-18,19,20,21-tetrahydro-15H,17H-12,8-(metheno)pyrazolo[3',4':2,3][1,5,10,12]oxatriazacycloheptadecino[12,11-a]benzimidazol-7(5H)-one |
|
 | | XXS | | Name: | 4-{4-[(3R)-3-methylmorpholin-4-yl]-6-[1-(S-methylsulfonimidoyl)cyclopropyl]pyrimidin-2-yl}-1H-indazole | | Formula: | C20 H24 N6 O2 S | | SMILES: | C1(C)COCCN1c5cc(C2(S(C)(=N)=O)CC2)nc(c4cccc3c4cnn3)n5 | | InChi: | InChI=1S/C20H24N6O2S/c1-13-12-28-9-8-26(13)18-10-17(20(6-7-20)29(2,21)27)23-19(24-18)14-4-3-5-16-15(14)11-22-25-16/h3-5,10-11,13,21H,6-9,12H2,1-2H3,(H,22,25)/t13-,29-/m1/s1 | | Definition date: | 2021-01-18 | | Last modified: | 2022-01-07 | | Release date: | 2022-01-12 | | Identifier: | 4-{4-[(3R)-3-methylmorpholin-4-yl]-6-[1-(S-methylsulfonimidoyl)cyclopropyl]pyrimidin-2-yl}-1H-indazole |
|
 | | 2JI | | Name: | (5-ethyl-2-methyl-1H-indol-3-yl)acetic acid | | Formula: | C13 H15 N O2 | | SMILES: | O=C(O)Cc1c2cc(ccc2[NH]c1C)CC | | InChi: | InChI=1S/C13H15NO2/c1-3-9-4-5-12-11(6-9)10(7-13(15)16)8(2)14-12/h4-6,14H,3,7H2,1-2H3,(H,15,16) | | Definition date: | 2021-06-30 | | Last modified: | 2022-01-07 | | Release date: | 2022-01-12 | | Identifier: | (5-ethyl-2-methyl-1H-indol-3-yl)acetic acid |
|
 | | Y5D | | Name: | {1-(ethylsulfonyl)-3-[4-(2-{[3-fluoro-4-(1-methylpiperidin-4-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile | | Formula: | C28 H32 F N9 O2 S | | SMILES: | c5c(c4c1c(ncc1)nc(Nc3ccc(C2CCN(C)CC2)c(c3)F)n4)cnn5C6(CN(C6)S(CC)(=O)=O)CC#N | | InChi: | InChI=1S/C28H32FN9O2S/c1-3-41(39,40)37-17-28(18-37,9-10-30)38-16-20(15-32-38)25-23-6-11-31-26(23)35-27(34-25)33-21-4-5-22(24(29)14-21)19-7-12-36(2)13-8-19/h4-6,11,14-16,19H,3,7-9,12-13,17-18H2,1-2H3,(H2,31,33,34,35) | | Definition date: | 2021-02-04 | | Last modified: | 2022-01-07 | | Release date: | 2022-01-12 | | Identifier: | {1-(ethylsulfonyl)-3-[4-(2-{[3-fluoro-4-(1-methylpiperidin-4-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile |
|
 | | Y5G | | Name: | {1-(ethylsulfonyl)-3-[4-(2-{[4-(1-methylpiperidin-4-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile | | Formula: | C28 H33 N9 O2 S | | SMILES: | c5c(c3c4c(nc(Nc2ccc(C1CCN(C)CC1)cc2)n3)ncc4)cnn5C6(CN(C6)S(CC)(=O)=O)CC#N | | InChi: | InChI=1S/C28H33N9O2S/c1-3-40(38,39)36-18-28(19-36,11-12-29)37-17-22(16-31-37)25-24-8-13-30-26(24)34-27(33-25)32-23-6-4-20(5-7-23)21-9-14-35(2)15-10-21/h4-8,13,16-17,21H,3,9-11,14-15,18-19H2,1-2H3,(H2,30,32,33,34) | | Definition date: | 2021-02-04 | | Last modified: | 2022-01-07 | | Release date: | 2022-01-12 | | Identifier: | {1-(ethylsulfonyl)-3-[4-(2-{[4-(1-methylpiperidin-4-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile |
|
 | | 2LZ | | Name: | (5-fluoro-1H-indol-3-yl)acetic acid | | Formula: | C10 H8 F N O2 | | SMILES: | O=C(O)Cc1c[NH]c2ccc(F)cc21 | | InChi: | InChI=1S/C10H8FNO2/c11-7-1-2-9-8(4-7)6(5-12-9)3-10(13)14/h1-2,4-5,12H,3H2,(H,13,14) | | Definition date: | 2021-06-30 | | Last modified: | 2022-01-07 | | Release date: | 2022-01-12 | | Identifier: | (5-fluoro-1H-indol-3-yl)acetic acid |
|
 | | XR4 | | Name: | N,N'-[(1,19-dioxo-4,7,10,13,16-pentaoxanonadecane-1,19-diyl)di(piperidine-1,4-diyl)]bis(4-{[4-({3-[(tert-butylsulfonyl)amino]-4-chlorophenyl}amino)-5-methylpyrimidin-2-yl]amino}-2-fluorobenzamide) | | Formula: | C68 H88 Cl2 F2 N14 O13 S2 | | SMILES: | c6(C(NC5CCN(C(=O)CCOCCOCCOCCOCCOCCC(N1CCC(CC1)NC(=O)c2c(cc(cc2)Nc3ncc(c(n3)Nc4cc(c(cc4)Cl)NS(C(C)(C)C)(=O)=O)C)F)=O)CC5)=O)ccc(cc6F)Nc7nc(c(C)cn7)Nc8ccc(c(c8)NS(C(C)(C)C)(=O)=O)Cl | | InChi: | InChI=1S/C68H88Cl2F2N14O13S2/c1-43-41-73-65(81-61(43)75-49-11-15-53(69)57(39-49)83-100(91,92)67(3,4)5)79-47-9-13-51(55(71)37-47)63(89)77-45-17-23-85(24-18-45)59(87)21-27-95-29-31-97-33-35-99-36-34-98-32-30-96-28-22-60(88)86-25-19-46(20-26-86)78-64(90)52-14-10-48(38-56(52)72)80-66-74-42-44(2)62(82-66)76-50-12-16-54(70)58(40-50)84-101(93,94)68(6,7)8/h9-16,37-42,45-46,83-84H,17-36H2,1-8H3,(H,77,89)(H,78,90)(H2,73,75,79,81)(H2,74,76,80,82) | | Definition date: | 2021-01-07 | | Last modified: | 2022-01-07 | | Release date: | 2022-01-12 | | Identifier: | N,N'-[(1,19-dioxo-4,7,10,13,16-pentaoxanonadecane-1,19-diyl)di(piperidine-1,4-diyl)]bis(4-{[4-({3-[(tert-butylsulfonyl)amino]-4-chlorophenyl}amino)-5-methylpyrimidin-2-yl]amino}-2-fluorobenzamide) |
|
 | | XR7 | | Name: | N,N'-(oxybis{(ethane-2,1-diyl)oxyethane-2,1-diyloxy[3-(2-methyl-1-oxo-1,2-dihydroisoquinolin-4-yl)-4,1-phenylene]})di(ethane-1-sulfonamide) | | Formula: | C44 H50 N4 O11 S2 | | SMILES: | c1(NS(CC)(=O)=O)ccc(c(c1)C=3c2ccccc2C(N(C=3)C)=O)OCCOCCOCCOCCOc4c(cc(cc4)NS(CC)(=O)=O)C5=CN(C)C(=O)c6ccccc56 | | InChi: | InChI=1S/C44H50N4O11S2/c1-5-60(51,52)45-31-15-17-41(37(27-31)39-29-47(3)43(49)35-13-9-7-11-33(35)39)58-25-23-56-21-19-55-20-22-57-24-26-59-42-18-16-32(46-61(53,54)6-2)28-38(42)40-30-48(4)44(50)36-14-10-8-12-34(36)40/h7-18,27-30,45-46H,5-6,19-26H2,1-4H3 | | Definition date: | 2021-01-07 | | Last modified: | 2022-01-07 | | Release date: | 2022-01-12 | | Identifier: | N,N'-(oxybis{(ethane-2,1-diyl)oxyethane-2,1-diyloxy[3-(2-methyl-1-oxo-1,2-dihydroisoquinolin-4-yl)-4,1-phenylene]})di(ethane-1-sulfonamide) |
|
